{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:54:42Z","timestamp":1761630882861,"version":"3.37.3"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T00:00:00Z","timestamp":1572307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI065256"],"award-info":[{"award-number":["R01AI065256"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0224523","type":"journal-article","created":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T17:32:37Z","timestamp":1572370357000},"page":"e0224523","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["CCR5 receptor antagonism inhibits hepatitis C virus (HCV) replication in vitro"],"prefix":"10.1371","volume":"14","author":[{"given":"Jason T.","family":"Blackard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan D.","family":"Rouster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebekah","family":"Karns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul S.","family":"Horn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shyam","family":"Kottilil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1907-0570","authenticated-orcid":true,"given":"M. Tarek","family":"Shata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0560-0019","authenticated-orcid":true,"given":"Kenneth E.","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,10,29]]},"reference":[{"issue":"7","key":"pone.0224523.ref001","doi-asserted-by":"crossref","first-page":"6040","DOI":"10.1128\/JVI.72.7.6040-6047.1998","article-title":"Exclusive and persistent use of the entry coreceptor CXCR4 by human immunodeficiency virus type 1 from a subject homozygous for CCR5 delta32","volume":"72","author":"NL Michael","year":"1998","journal-title":"J Virol"},{"issue":"5","key":"pone.0224523.ref002","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/00042560-200108150-00009","article-title":"Homozygous and heterozygous CCR5-Delta32 genotypes are associated with resistance to HIV infection","volume":"27","author":"M Marmor","year":"2001","journal-title":"Journal of acquired immune deficiency syndromes"},{"issue":"3","key":"pone.0224523.ref003","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nm0398-350","article-title":"A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation","volume":"4","author":"LG Kostrikis","year":"1998","journal-title":"Nature medicine"},{"issue":"1","key":"pone.0224523.ref004","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/hep.21283","article-title":"Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences","volume":"44","author":"JT Blackard","year":"2006","journal-title":"Hepatology"},{"issue":"5","key":"pone.0224523.ref005","doi-asserted-by":"crossref","first-page":"G949","DOI":"10.1152\/ajpgi.00215.2003","article-title":"Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migration","volume":"285","author":"RF Schwabe","year":"2003","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"8","key":"pone.0224523.ref006","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1093\/intimm\/13.8.1021","article-title":"Human CC chemokine liver-expressed chemokine\/CCL16 is a functional ligand for CCR1, CCR2 and CCR5, and constitutively expressed by hepatocytes","volume":"13","author":"H Nomiyama","year":"2001","journal-title":"Int Immunol"},{"issue":"3","key":"pone.0224523.ref007","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/2047-783X-15-3-97","article-title":"The role of CCR5 in HCV infection","volume":"15","author":"M Coenen","year":"2010","journal-title":"Eur J Med Res"},{"issue":"1","key":"pone.0224523.ref008","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s00109-003-0505-0","article-title":"CC chemokine receptor 5 delta32 polymorphism in two independent cohorts of hepatitis C virus infected patients without hemophilia","volume":"82","author":"HE Wasmuth","year":"2004","journal-title":"J Mol Med (Berl)"},{"issue":"3\u20134","key":"pone.0224523.ref009","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1080\/08820130902832035","article-title":"Effects of the CCR5-Delta32 mutation on hepatitis C virus-specific immune responses in patients with haemophilia","volume":"38","author":"G Ahlenstiel","year":"2009","journal-title":"Immunol Invest"},{"issue":"6","key":"pone.0224523.ref010","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2370.2004.00482.x","article-title":"The CCR5 Delta 32 allele is associated with reduced liver inflammation in hepatitis C virus infection","volume":"31","author":"O Wald","year":"2004","journal-title":"Eur J Immunogenet"},{"issue":"3","key":"pone.0224523.ref011","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3851\/IMP3116","article-title":"Hepatic safety of maraviroc in patients with HIV-1 and hepatitis C and\/or B virus: 144-week results from a randomized, placebo-controlled trial","volume":"22","author":"JK Rockstroh","year":"2017","journal-title":"Antiviral therapy"},{"key":"pone.0224523.ref012","article-title":"A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis","author":"SL Friedman","year":"2017","journal-title":"Hepatology"},{"issue":"6","key":"pone.0224523.ref013","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/QAD.0000000000000988","article-title":"A 48-week randomized phase 2b study evaluating cenicriviroc versus efavirenz in treatment-naive HIV-infected adults with C-C chemokine receptor type 5-tropic virus","volume":"30","author":"M Thompson","year":"2016","journal-title":"Aids"},{"key":"pone.0224523.ref014","article-title":"Improvement in Hepatic Fibrosis Biomarkers Associated with Chemokine Receptor Inactivation through Mutation or Therapeutic Blockade","author":"KE Sherman","year":"2018","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"22","key":"pone.0224523.ref015","doi-asserted-by":"crossref","first-page":"13963","DOI":"10.1128\/JVI.79.22.13963-13973.2005","article-title":"Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells","volume":"79","author":"Z Cai","year":"2005","journal-title":"Journal of Virology"},{"issue":"7","key":"pone.0224523.ref016","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1089\/thy.2012.0507","article-title":"Hepatitis C virus infection of a thyroid cell line: implications for pathogenesis of hepatitis C virus and thyroiditis","volume":"23","author":"JT Blackard","year":"2013","journal-title":"Thyroid"},{"key":"pone.0224523.ref017","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jviromet.2005.10.014","article-title":"Cell-based models of sustained, interferon-sensitive hepatitis C virus genotype 1 replication","volume":"132","author":"Y Hiasa","year":"2006","journal-title":"Journal of Virologic Methods"},{"issue":"6","key":"pone.0224523.ref018","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1128\/JVI.64.6.2553-2559.1990","article-title":"CD4-independent, productive human immunodeficiency virus type 1 infection of hepatoma cell lines in vitro","volume":"64","author":"YZ Cao","year":"1990","journal-title":"Journal of Virology"},{"issue":"10","key":"pone.0224523.ref019","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1097\/00002030-199210000-00010","article-title":"Inhibition of HIV-1 productive infection in hepatoblastoma HepG2 cells by recombinant tumor necrosis factor-a","volume":"6","author":"R Banerjee","year":"1992","journal-title":"Aids"},{"key":"pone.0224523.ref020","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1086\/378643","article-title":"Hepatitis C and human immunodeficiency virus envelope proteins cooperatively induce hepatocytic apoptosis via an innocent bystander mechanism","volume":"188","author":"N Munshi","year":"2003","journal-title":"Journal of Infectious Diseases"},{"issue":"37","key":"pone.0224523.ref021","doi-asserted-by":"crossref","first-page":"35755","DOI":"10.1074\/jbc.M302889200","article-title":"HCV and HIV envelope proteins collaboratively mediate IL-8 secretion through activation of p38 MAP kinase and SHP2 in hepatocytes","volume":"278","author":"A Balasubramanian","year":"2003","journal-title":"Journal of Biological Chemistry"},{"key":"pone.0224523.ref022","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1086\/379738","article-title":"Human immunodeficiency virus-induced apoptosis of human hepatocytes via CXCR4","volume":"188","author":"S Vlahakis","year":"2003","journal-title":"Journal of Infectious Diseases"},{"issue":"12","key":"pone.0224523.ref023","doi-asserted-by":"crossref","first-page":"5860","DOI":"10.1128\/JVI.02594-09","article-title":"Coinfection of hepatic cell lines with human immunodeficiency virus and hepatitis B virus leads to an increase in intracellular hepatitis B surface antigen","volume":"84","author":"DM Iser","year":"2010","journal-title":"Journal of Virology"},{"issue":"14","key":"pone.0224523.ref024","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1097\/QAD.0b013e328308937c","article-title":"Characterization of a CD4-independent clinical HIV-1 that can efficiently infect human hepatocytes through chemokine (C-X-C motif) receptor 4","volume":"22","author":"P Xiao","year":"2008","journal-title":"AIDS"},{"key":"pone.0224523.ref025","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.virol.2009.12.008","article-title":"Human hepatoma cells transmit surface bound HIV-1 to CD4+ T cells through an ICAM-1\/LFA-1-dependent mechanism","volume":"398","author":"R Fromentin","year":"2010","journal-title":"Virology"},{"issue":"1","key":"pone.0224523.ref026","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/1743-422X-9-157","article-title":"Low-level HIV infection of hepatocytes","volume":"9","author":"L Kong","year":"2012","journal-title":"Virology Journal"},{"issue":"1","key":"pone.0224523.ref027","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.antiviral.2012.07.005","article-title":"Anti-retroviral drugs do not facilitate hepatitis C virus (HCV) infection in vitro","volume":"96","author":"L Sandmann","year":"2012","journal-title":"Antiviral research"},{"issue":"2","key":"pone.0224523.ref028","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1179\/1528433614Z.0000000011","article-title":"Hepatic safety in subjects with HIV-1 and hepatitis C and\/or B virus: a randomized, double-blind study of maraviroc versus placebo in combination with antiretroviral agents","volume":"16","author":"JK Rockstroh","year":"2015","journal-title":"HIV Clin Trials"},{"issue":"246","key":"pone.0224523.ref029","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1126\/scitranslmed.3008195","article-title":"Modulation of HCV replication after combination antiretroviral therapy in HCV\/HIV co-infected patients","volume":"6","author":"KE Sherman","year":"2014","journal-title":"Science translational medicine"},{"key":"pone.0224523.ref030","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3389\/fphys.2012.00213","article-title":"The role of chemokines in acute liver injury","volume":"3","author":"Y Saiman","year":"2012","journal-title":"Front Physiol"},{"issue":"3","key":"pone.0224523.ref031","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/hep.24763","article-title":"Activation of chemokine and inflammatory cytokine response in hepatitis C virus-infected hepatocytes depends on Toll-like receptor 3 sensing of hepatitis C virus double-stranded RNA intermediates","volume":"55","author":"K Li","year":"2012","journal-title":"Hepatology"},{"issue":"14","key":"pone.0224523.ref032","doi-asserted-by":"crossref","first-page":"8169","DOI":"10.1128\/JVI.00974-13","article-title":"Hepatitis C virus infection induces inflammatory cytokines and chemokines mediated by the cross talk between hepatocytes and stellate cells","volume":"87","author":"H Nishitsuji","year":"2013","journal-title":"Journal of virology"},{"issue":"1","key":"pone.0224523.ref033","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cellimm.2003.10.005","article-title":"Interleukin-1beta induces macrophage inflammatory protein-1beta expression in human hepatocytes","volume":"226","author":"T Zhang","year":"2003","journal-title":"Cell Immunol"},{"issue":"9","key":"pone.0224523.ref034","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.bbalip.2018.06.002","article-title":"Complex lipid metabolic remodeling is required for efficient hepatitis C virus replication","volume":"1863","author":"S Hofmann","year":"2018","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"3","key":"pone.0224523.ref035","doi-asserted-by":"crossref","DOI":"10.3390\/cells8030233","article-title":"HCV Pit Stop at the Lipid Droplet: Refuel Lipids and Put on a Lipoprotein Coat before Exit","volume":"8","author":"G Vieyres","year":"2019","journal-title":"Cells"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0224523","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T08:41:28Z","timestamp":1611650488000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0224523"}},"subtitle":[],"editor":[{"given":"Ratna B.","family":"Ray","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,10,29]]},"references-count":35,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0224523","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2019,10,29]]}}}